Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.
Today the body that recommends what can and cannot be paid for said it 'wasn't cost effective'.
Prostate cancer patients have now been told that the life-extending drug will not be routinely prescribed unless they have chemotherapy.
One man from North Yorkshire who is fighting prostate cancer is calling for a rethink:
More top news
Historic mills across the North are disappearing fast despite massive public support against demolition, Historic England has claimed.
Barnsley singer Holly Tandy has been voted out of this year's X Factor. She was one of the two acts with the fewest votes on Sunday night.
A man bitten by a spider needed hospital treatment in Tenerife after the wound became badly infected whilst on holiday.